silybin has been researched along with Keloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S; Ham, S; Kim, J; Lee, JH; Lee, WJ; Lee, YI | 1 |
| Cho, JW; Il, KJ; Lee, KS | 1 |
2 other study(ies) available for silybin and Keloid
| Article | Year |
|---|---|
Silibinin Downregulates Types I and III Collagen Expression via Suppression of the mTOR Signaling Pathway.
Topics: Animals; Collagen; Collagen Type I; Humans; Keloid; Mammals; Signal Transduction; Silybin; TOR Serine-Threonine Kinases | 2023 |
Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
Topics: Cell Death; Cell Nucleus; Cell Proliferation; Chemoprevention; Collagen Type I; Down-Regulation; Fibroblasts; Humans; Keloid; Matrix Metalloproteinases; Phosphorylation; Promoter Regions, Genetic; Signal Transduction; Silybin; Silymarin; Skin; Smad Proteins; Smad2 Protein; Smad3 Protein; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1 | 2013 |